Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: gsk
gsk
Update Il y a 5 ans
Assessment of coincident Nausea and Vomiting (N&V) with upper gastrointestinal bleeding (UGIB) in Cancer Patients Treated with Chemotherapy: Results from Pooled Clinical Trials Data
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
gsk
Update Il y a 5 ans
PGx421:Exploratory genetic evaluation of efficacy and safety endpoints in pazopanib-treated patients with soft tissue sarcoma in VEG110727
This pharmacogenetic analysis uses data from clinical study VEG110727. The objective is to identify germline genetic markers in candidate genes associated with efficacy and safety endpoints in pazopan...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
gsk
Update Il y a 5 ans
A Randomized, Multi-Center, Blinded, Placebo-Controlled Study of Mapatumumab ([HGS1012], a Fully-Human Monoclonal Antibody to TRAIL-R1) in Combination with Sorafenib as a First-Line Therapy in Subjects with Advanced Hepatocellular Carcinoma
Mapatumumab is a fully human, agonist monoclonal antibody that activates the cell death pathway in tumor cells by specifically binding to TRAIL-R1 with high affinity. Sorafenib, a multikinase inhibito...
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
A single dose, two-period crossover study to compare the bioavailability of paroxetine from the enteric-coated Geomatrix controlled-release paroxetine tablet (50 mg) when administered in the fasted state and after a standard FDA high-fat breakfast
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
Etoposide, Topotecan and Paclitaxel, “Etopotax” in Patients with Refractory Malignancy: A Phase I Trial
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
A Study to Assess the Effectiveness and Tolerance of Paroxetine by Double-Blind Comparison with Placebo and Mianserin
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
A phase III, double-blind, randomized, multicenter primary vaccination study to bridge the DTPa-HBV-IPV vaccine manufactured according to the large scale manufacturing process with the DTPa-HBV-IPV vaccine manufactured by the small scale manufacturing process when administered intramuscularly to infants at 2, 4 and 6 months of age, co-administered with Merck's Hib conjugate vaccine (Liquid PedvaxHIB®) in a separate injection at 2 and 4 months of age
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
gsk
Update Il y a 5 ans
Meta-Analysis in sponsored studies MEA112997, MEA115588, and MEA115575 and a proof of concept investigator sponsored study CRT110184 of Mepolizumab in Severe Asthma
The analyses described in this document are being conducted to generate estimates of the effect of mepolizumab on exacerbations requiring hospitalisation/ED visits and hospitalisation alone which are ...
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
A 12-week, Multicentre, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Anti-inflammatory Activity of SB207499 15 mg Twice Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
Epidemiologische Nachuntersuchung von Patienten der Studie Avandamet 712753 / 100420 (Ziel-Studie)
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
8
9
10
11
12
13
14
15
16
17
Next